SPN-830

Potential FDA approval for Supernus’s SPN-830 in Parkinson’s but challenges remain
Clinical Trials Arena
Mon, 10/16/23 - 10:18 am
Supernus
SPN-830
Parkinson's Disease
FDA
Working its way through a CRL on lead drug, Supernus taps $150M loan
Endpoints
Wed, 02/15/23 - 06:17 pm
Supernus Pharmaceuticals
FDA
Parkinson's Disease
SPN-830
FDA spurns Supernus for Parkinson's drug, noting application issues 'across several areas'
Endpoints
Mon, 10/10/22 - 06:47 pm
Supernus Pharmaceuticals
FDA
Parkinson's Disease
SPN-830
FDA hits Supernus with double whammy, handing biotech a CRL and RTF on same day
Endpoints
Tue, 11/10/20 - 10:40 am
Supernus
FDA
SPN-812
ADHD
SPN-830
Parkinson's Disease